Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-04

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for labetalol hydrochloride (Hospira, Inc.), supporting the generic drug's availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)